Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Apart from slightly lower-than-normal 25-hydroxyvitamin D concentrations and modest elevations in total cholesterol and LDL cholesterol, the remaining laboratory parameters were within the normal range.
Source: 3.1. Descriptive Statistics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Chronotype and FibroScan-Derived Liver Markers in Adults with Obesity: Preliminary Evidence from a Cross-Sectional Study
Source: Article title.
Participants were excluded in the presence of previously diagnosed diabetes mellitus, cardiovascular disease, respiratory insufficiency, severe gastrointestinal disorders, chronic kidney disease (estimated glomerular filtration rate < 60 mL/min/1.73 m2), psychiatric illness, pregnancy or breastfeeding, eating disorders, chronic liver disease unrelated to metabolic dysfunction, alcohol intake above 30 g/day in men or 20 g/day in women, substance abuse, frailty, acute infectious or inflammatory conditions that could influence inflammatory markers, or rare inherited metabolic disorders such as porphyria, carnitine deficiency, carnitine palmitoyl transferase deficiency, carnitine: acylcarnitine translocase deficiency, pyruvate carboxylase deficiency, and disorders of mitochondrial fatty acid oxidation.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Chronotype and FibroScan-Derived Liver Markers in Adults with Obesity: Preliminary Evidence from a Cross-Sectional Study
Cross-sectional study · Nutrients · 2026
Original publication title
Chronotype and FibroScan-Derived Liver Markers in Adults with Obesity: Preliminary Evidence from a Cross-Sectional Study
© 2026 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Background/Objectives
Chronotype describes individual preferences regarding the timing of sleep, food intake, and other daily activities and is commonly evaluated using the Morningness: Eveningness Questionnaire (MEQ). Individuals with a morning chronotype generally prefer earlier sleep: wake schedules, whereas those with an evening chronotype exhibit delayed circadian timing and achieve peak alertness later in the day. Previous evidence has linked evening chronotype to an elevated risk of obesity and metabolic dysfunction; however, its association with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), particularly with hepatic steatosis and fibrosis, has not yet been fully elucidated.
Source: Background/Objectives:Abstract: Results
Hepatic steatosis was detected in 62% of participants (n = 74), whereas fibrosis was identified in 15% (n = 18). When chronotype was analyzed as a continuous variable, no significant correlations were observed with either CAP (r = 0.017, p = 0.852) or liver stiffness measurements (r = −0.045, p = 0.629). Although these associations did not reach statistical significance, the corresponding confidence intervals remained compatible with small-to-moderate effect sizes, particularly for fibrosis, reflecting the limited number of participants with fibrotic disease.
Source: Results:Abstract: Conclusions
In this sample, chronotype was not significantly associated with FibroScan-derived measures of hepatic steatosis or fibrosis. Associations with selected metabolic and behavioral characteristics were identified, although these findings require confirmation in adequately powered longitudinal investigations. To our knowledge, only a limited number of studies have explored these relationships using objective FibroScan-derived measurements in medication-naïve individuals. Consequently, the present findings should be considered hypothesis-generating and warrant validation in larger prospective cohorts.
Source: Conclusions:Authors’ abstract
Background/Objectives:
Chronotype describes individual preferences regarding the timing of sleep, food intake, and other daily activities and is commonly evaluated using the Morningness: Eveningness Questionnaire (MEQ). Individuals with a morning chronotype generally prefer earlier sleep: wake schedules, whereas those with an evening chronotype exhibit delayed circadian timing and achieve peak alertness later in the day. Previous evidence has linked evening chronotype to an elevated risk of obesity and metabolic dysfunction; however, its association with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), particularly with hepatic steatosis and fibrosis, has not yet been fully elucidated.
Methods:
This cross-sectional study included 119 medication-naïve adults, predominantly with obesity (mean age 41.5 ± 11.9 years; 58 men, 49%), recruited at the Nutrition Center of the National Institute of Gastroenterology “Saverio de Bellis.” Hepatic steatosis (controlled attenuation parameter [CAP] > 275 dB/m) and liver fibrosis (liver stiffness > 8.2 kPa) were assessed by transient elastography (FibroScan).
Results:
Hepatic steatosis was detected in 62% of participants (n = 74), whereas fibrosis was identified in 15% (n = 18). When chronotype was analyzed as a continuous variable, no significant correlations were observed with either CAP (r = 0.017, p = 0.852) or liver stiffness measurements (r = −0.045, p = 0.629). Although these associations did not reach statistical significance, the corresponding confidence intervals remained compatible with small-to-moderate effect sizes, particularly for fibrosis, reflecting the limited number of participants with fibrotic disease.
Conclusions:
In this sample, chronotype was not significantly associated with FibroScan-derived measures of hepatic steatosis or fibrosis. Associations with selected metabolic and behavioral characteristics were identified, although these findings require confirmation in adequately powered longitudinal investigations. To our knowledge, only a limited number of studies have explored these relationships using objective FibroScan-derived measurements in medication-naïve individuals. Consequently, the present findings should be considered hypothesis-generating and warrant validation in larger prospective cohorts.
Publication and source details
Original title: Chronotype and FibroScan-Derived Liver Markers in Adults with Obesity: Preliminary Evidence from a Cross-Sectional Study
Nicole Cerabino; Davide Guido; Leonilde Bonfrate; Endrit Shahini; Vincenza Di Stasi; Martina Di Chito; Maria Noemy Pastore; Sergio Coletta; Anna Ancona; Gianluigi Giannelli; Giovanni De Pergola
Nutrients · 2026
* Correspondence: davide.guido@irccsdebellis.it© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.Italian Ministry of HealthThe research was funded by the Italian Ministry of Health “Ricerca Corrente 2024 to 2026”.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:06:42.240795+00:00
DOI: 10.3390/nu18142342 · PMC13415371